The Cheapest Way to Get Semaglutide: Every Legal Route and Price
The cheapest legal route is Novo Nordisk's Patient Assistance Program, which supplies medicine free to approved applicants with Medicare or no insurance. Medicare's GLP-1 Bridge runs $50 a month. With commercial insurance, the savings offer is $25 a month for up to 3 months; cash prices start at $149.
Semaglutides.org provides information only, not medical advice. Talk to a licensed provider about your own care before making changes. Some telehealth links are affiliate links and are labeled where they appear.
The cheapest legal way to get semaglutide depends on your insurance situation. For approved applicants with Medicare or no insurance, the Novo Nordisk Patient Assistance Program supplies the medicine at no cost, with no registration charge or monthly fee [4]. On Medicare Part D, the GLP-1 Bridge program charges a $50 monthly copayment starting July 1, 2026 [3]. With commercial insurance, Novo Nordisk’s savings offer brings Wegovy or Ozempic down to as little as $25 a month for up to 3 months, subject to a maximum savings of $100 a month [1][2][5][6].
Paying cash, the floor is lower than it used to be. Oral semaglutide (the Wegovy or Ozempic pill) starts at $149 a month [2][5][6], a new-patient offer puts the two lowest pen doses at $199 a month for two fills [2][5][6], and a 12-month Wegovy pen subscription costs $249 a month [7][8]. The standard self-pay pen price is $349 a month [2][5][8][9]. None of these prices are guaranteed — Novo Nordisk states it can modify or cancel its programs at any time [2][5][4].
What does each legal route cost at a glance?
| Route | What you pay | Who it’s for |
|---|---|---|
| Novo Nordisk Patient Assistance Program | No cost, no registration charge or monthly fee [4] | Approved applicants with Medicare or no insurance |
| Medicare GLP-1 Bridge | $50 monthly copayment [3] | Medicare Part D members meeting BMI and health criteria |
| Commercial-insurance savings offer | As little as $25/mo for up to 3 months (max savings $100/mo) [1][2][5][6] | People with commercial insurance |
| Oral semaglutide self-pay | $149–$299/mo depending on dose [2][5][6] | Cash payers |
| Wegovy pen 12-month subscription | $249/mo [7][8] | Self-pay patients committing to a year |
| New-patient pen offer | $199/mo for first 2 fills (0.25 mg, 0.5 mg) [2][5][9] | Patients new to the savings offer and NovoCare Pharmacy |
| Standard self-pay pen | $349/mo [2][5][8][9] | Self-pay patients after intro fills |
| Wegovy HD 7.2 mg / Ozempic 2 mg | $399/mo / $499/mo [2][5] | Self-pay patients on the highest doses |
How does the $25-a-month savings offer work with commercial insurance?
With commercial insurance, the Wegovy pill, Wegovy pen, and Wegovy HD pen all carry a “pay as little as $25” price, subject to a maximum savings of $100 a month [5]. The same applies to the Ozempic pill and pen at all doses [2]. NovoCare’s pharmacy page describes the $25 price as applying “for up to 3 months” with insurance [6]; the price guides state the $100 monthly savings cap without listing a duration [2][5].
There are conditions. The $25 copay pricing is available only for local pharmacy pickup with a savings offer [2][5]. Government beneficiaries are excluded [2][5]. Enrollment happens by texting SAVE to 83757 or filling out the online form [1]. The offer requires enrollees to be 18 or older, residents of the US, Puerto Rico, or a US territory, with a valid prescription [1].
Government plans listed as excluded include Medicare, Medigap, VA, DOD, TRICARE, and Medicaid — and people with both commercial and government coverage are treated as government beneficiaries [1]. However, FEHB plans, Affordable Care Act exchange plans, and state employee plans are not counted as government programs for this offer [1].
A “month” is defined as one box of 4 Wegovy pens, one box of 1 Ozempic pen, or one bottle of 30 tablets [2][5]. Novo Nordisk can modify or cancel the program at any time [2][5].
What is the Medicare GLP-1 Bridge and who qualifies?
Starting July 1, 2026, Medicare covers certain GLP-1 drugs under the Medicare GLP-1 Bridge program for a $50 monthly copayment [3]. The covered drugs are the Wegovy injection or tablet, the Foundayo tablet, and Zepbound KwikPen only — single-dose Zepbound vials or pens are not covered [3].
The program is temporary and available nationwide, including all states and US territories, to people with Part D coverage through a standalone PDP, a Medicare Advantage plan with drug coverage (HMO, HMOPOS, local and regional PPO), a Special Needs Plan, an Employer/union group waiver plan, or the LI NET program [3].
Eligibility is based on age, BMI, and health conditions. It requires being 18 or older and meeting one of these when starting GLP-1 therapy: a BMI of 35 or higher; a BMI of 30 or higher with diastolic heart failure, uncontrolled hypertension, or chronic kidney disease at stage 3a or higher; or a BMI of 27 or higher with prediabetes, a previous heart attack or stroke, or symptomatic peripheral artery disease [3].
The program excludes people whose Part D plan already covers their GLP-1, and people with type 2 diabetes, moderate-to-severe sleep apnea, or fatty liver disease — though the Part D plan might cover the GLP-1 in those cases [3]. Providers are required to send the prescription, complete a prior authorization when requested, and certify that the drug is being used alongside a diet-and-exercise lifestyle program [3]. Once approved, the prior authorization is valid, including refills and dose changes, through December 31, 2027, unless the patient switches GLP-1s [3].
Pharmacies may ask for a Medicare Number or the last 4 digits of a Social Security Number. Medicare lists a fraud line at 1-800-MEDICARE (1-800-633-4227), with TTY at 1-877-486-2048 [3]. An approval letter is mailed to the enrollee [3].
One cost trap to know: discount cards, including TrumpRx, are not creditable coverage, and spending through them does not count toward the Medicare deductible or out-of-pocket maximum [3]. Medicare.gov points consumers to TrumpRx.gov to compare cash prices, but drugs cannot be bought directly from TrumpRx [3].
Can you get semaglutide completely free?
Yes, through the Novo Nordisk Patient Assistance Program. It provides medicine at no cost to approved applicants, with no registration charge or monthly fee [4].
For 2026, eligibility requires US citizenship or legal residency, a qualifying household income, and Medicare or no insurance — private or commercial insurance disqualifies an applicant [4]. The program also excludes anyone enrolled in or eligible for Medicaid, Medicare LIS (Extra Help), or VA benefits; applicants eligible for Medicaid or LIS are asked to submit a denial letter with the application [4].
For uninsured patients, household income must be at or below 200% of the federal poverty level for Ozempic, and at or below 400% of the FPL for all other covered medications [4]. The program references FPL guidelines through the NeedyMeds website [4]. Medicare beneficiaries with prescription drug coverage are no longer eligible to receive Ozempic through the PAP [4].
A complete application is processed within 2 business days, and once approved, medicine ships to the home within 5 business days [4]. Delivery is scheduled by Neovance Specialty Pharmacy at 1-800-488-5908; shipping costs are covered, and the program cannot ship to a pharmacy [4]. Uninsured patients are enrolled for 12 months; Medicare patients are enrolled through the end of the current calendar year [4]. Medicare Part D applicants are no longer required to spend $1,000 out of pocket first [4].
The program is listed under Novo Nordisk diabetes products, and some medicines have been dropped from the PAP for 2026 — the PAP product list shows which medicines remain covered [4]. Program questions go to 1-866-310-7549 [4].
What is the cheapest cash option — the pill or the pen?
The pill. Wegovy pill self-pay prices are $149 a month for 1.5 mg, $199 for 4.0 mg, and $299 for both the 9 mg and 25 mg doses [5][6]. Ozempic pill self-pay prices are $149 a month for 1.5 mg, $199 for 4.0 mg, and $299 for 9 mg [2]. One month equals one bottle of 30 tablets [2][5][6].
Self-pay pricing is available for local pharmacy pickup with a savings offer or for home delivery [2][5]. All doses of Wegovy and Ozempic require a prescription [6].
How does the Wegovy subscription work?
Novo Nordisk launched a multi-month subscription program on March 31, 2026, through Ro, WeightWatchers, and LifeMD, with Hims & Hers, Sesame, and others to follow [7][8]. Eligible self-pay patients can choose 3-, 6-, or 12-month subscriptions, with longer terms costing less per month [7].
For the Wegovy pen (0.25, 0.5, 1, 1.7, and 2.4 mg), a 3-month subscription costs $329 a month, a 6-month costs $299, and a 12-month costs $249 [7][8]. Those work out to savings of $240, $600, and $1,200 per year respectively [7]. For the Wegovy pill at 9 mg and 25 mg, subscriptions run $289, $269, and $249 a month, saving up to $600 a year [7].
Reuters reported that the pen subscription prices run roughly 6% to 29% below the standard $349 monthly price, and the pill about 3% to 17% below its standard $299 [8]. Wegovy HD 7.2 mg will be added to the subscription later [7].
For the Wegovy pill at 1.5 mg and 4 mg, self-pay patients pay $149 a month, with the 4 mg offer available until August 31, 2026, after which it becomes $199 a month [7]. Limited-time offers are separate from and not included in the subscriptions, and terms vary by telehealth platform — the announcement directs patients to contact their telehealth provider for eligibility and full terms [7].
What is the $199 introductory offer, and what happens after?
Patients new to the Wegovy or Ozempic savings offer and NovoCare Pharmacy pay $199 a month for the 0.25 mg and 0.5 mg doses [2][5][6]. The offer covers 2 monthly fills and is available through December 31, 2026 [2][5][6].
After those fills, Wegovy costs $349 a month for the 0.25, 0.5, 1, 1.7, and 2.4 mg doses, and $399 a month for Wegovy HD 7.2 mg [5][6]. Ozempic costs $349 a month for the 0.25, 0.5, and 1 mg doses, and $499 a month for the 2 mg dose [2][6].
The offer was originally announced on November 17, 2025, and was initially framed as running to March 31, 2026 before later price guides extended it to December 31, 2026 [9][2][5]. On that same November 17, 2025 date, the standard self-pay price was cut from $499 to $349 a month, a roughly 30% reduction [9][8].
Where do you actually buy at these prices?
Registration is available at wegovy.com or ozempic.com, and the savings can be used at more than 70,000 US pharmacy locations [9][7]. Through NovoCare Pharmacy, a prescriber sends the prescription, and the patient gets free home delivery or pickup at over 9,000 CVS retail locations [9][6].
Other organizations named in the November 2025 launch include Costco, GoodRx, WeightWatchers, Ro, LifeMD, and eMed [9]. NovoCare Pharmacy also offers a telehealth prescriber connection for people without a prescriber [6].
How do other GLP-1 prices compare?
Zepbound (tirzepatide) self-pay prices under Lilly’s Self Pay Journey Program start at $299 a month for the 2.5 mg dose, $399 for 5 mg, and $449 for 7.5 mg and higher doses [8]. Foundayo, a tablet, is one of the drugs covered at the $50 copayment under the Medicare GLP-1 Bridge [3]. Lilly reported in September 2026 that Foundayo had captured over 30% of new US patients on oral weight-loss drugs [8].
Is compounded semaglutide still the cheap workaround?
NovoCare Pharmacy’s own framing is blunt: “We are FDA-approved. Compound semaglutides are not” [6]. Reuters reported that Novo and Lilly are explicitly steering patients away from cheaper compounded copies toward branded, FDA-approved products through direct and telehealth channels [8].
The price gap has narrowed. The branded self-pay floor is now $149 a month for the pill and $249 a month for the 12-month pen subscription [5][7], which shrinks whatever advantage compounding once had on price. Advertised compounded prices are not verified transaction prices.
What fine print changes which route is truly cheapest?
Self-pay purchases operate outside third-party insurance. The money spent does not count toward a deductible or out-of-pocket requirements and cannot be submitted for reimbursement [1]. The terms require buyers to disclose, if asked by their insurer, that the medicine was bought outside the plan using the self-pay offer and that no reimbursement is being sought [1]. Government-insured patients may still pay the self-pay price under the same enrollment [1].
Novo Nordisk reserves the right to modify or cancel its savings and self-pay programs at any time [2][5][4]. Dated expirations matter: the $199 intro offer runs through December 31, 2026 [2][5]; the Wegovy pill 4 mg $149 offer ended August 31, 2026 [7]; and Medicare Bridge prior authorizations run through December 31, 2027 [3]. Full terms are posted at WegovyTerms.com, SavingsCardEligibility.com, and NovoCarePharmacyTerms.com [2][5][1].
Which route fits your situation?
For approved applicants with Medicare or no insurance, the Patient Assistance Program supplies the medicine at no cost [4]. With Medicare Part D but no GLP-1 coverage, and meeting the BMI and health criteria, the $50 Bridge copayment applies [3]. With commercial coverage, the savings offer at $25 a month for up to 3 months (with a $100 monthly cap on savings) beats every cash price shown [1][2][5][6].
Uninsured people with household income at or below 200% of the federal poverty level who take Ozempic can get it at no cost through the PAP [4]. Cash payers wanting the lowest sticker price can look at oral semaglutide from $149 a month [5][6]. Cash payers who need the injection long-term can consider the 12-month subscription at $249 a month [7]. Which medicine and dose is appropriate is a decision for the patient and their prescriber — these figures are cost comparisons only.
Sources
- NovoCare. Savings Offer Program for Wegovy (semaglutide).
- Novo Nordisk. Ozempic pill and pen price guide.
- Medicare. Weight loss drugs.
- NovoCare. Novo Nordisk Patient Assistance Program (PAP).
- Novo Nordisk. Wegovy price guide.
- NovoCare. Get your GLP-1 medications delivered with NovoCare Pharmacy.
- PR Newswire. Novo Nordisk launches first and only multi-month subscription program for FDA-approved Wegovy, offering savings of up to $1,200/year.
- Reuters. Novo Nordisk to launch discounted Wegovy subscriptions for self-pay patients in US. March 31, 2026.
- PR Newswire. Novo Nordisk launches introductory self-pay offer for Wegovy and Ozempic for $199 per month. November 17, 2025.
- GoodRx. GoodRx launches new $39 per month weight loss telemedicine subscription, unveils industry-leading introductory cash price of $199 per month for Ozempic and Wegovy. November 17, 2025.
- TrumpRx. Ozempic Pen.
- Eli Lilly and Company. Foundayo (orforglipron) coverage and savings: self-pay and savings card.
- Eli Lilly and Company. Lilly lowers the price of Zepbound (tirzepatide) single-dose vials. December 1, 2025.
- US Food and Drug Administration. FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize.
- TrumpRx. TrumpRx.
Frequently asked questions
Can I get the $25-a-month price without insurance?
No. The $25 copay pricing applies only with commercial insurance and a savings offer at a local pharmacy, for up to 3 months. Government beneficiaries are excluded. Without insurance, the lowest published cash price is $149 a month for oral semaglutide.
Who is excluded from the $25 copay offer?
People enrolled in government programs: Medicare, Medigap, VA, DOD, TRICARE, and Medicaid. Those with both commercial and government coverage are treated as government beneficiaries. FEHB, ACA exchange plans, and state employee plans are not counted as government programs for this offer.
When does the Medicare GLP-1 Bridge start and end?
It starts July 1, 2026, with a $50 monthly copayment. It is described as a temporary, nationwide program. Prior authorizations, including refills and dose changes, are valid through December 31, 2027, unless the patient switches GLP-1s.
Does having type 2 diabetes block Medicare GLP-1 Bridge eligibility?
Yes. The program excludes people with type 2 diabetes, moderate-to-severe sleep apnea, or fatty liver disease — though the Part D plan might cover the GLP-1 for those conditions. It also excludes anyone whose Part D plan already covers their GLP-1.
What income cutoff gets Ozempic free from the manufacturer?
For uninsured patients, total household income must be at or below 200% of the federal poverty level for Ozempic; other covered medications use a 400% cutoff. The program also excludes anyone who qualifies for Medicaid, Medicare LIS, or VA benefits, with a denial letter required from applicants eligible for Medicaid or LIS.
Does the patient assistance program cover Wegovy for weight loss?
The PAP is listed under Novo Nordisk diabetes products, and some medicines were dropped for 2026, so coverage depends on the current PAP product list. Private or commercial insurance disqualifies an applicant entirely; the program requires Medicare or no insurance.
Does the $199 introductory price apply to higher doses?
No. It covers only the two lowest pen doses, 0.25 mg and 0.5 mg, for patients new to the savings offer and NovoCare Pharmacy. After two fills, Wegovy runs $349 a month (or $399 for HD 7.2 mg) and Ozempic $349, or $499 for the 2 mg dose.
How long does the $199 introductory price last?
It covers 2 monthly fills and is available through December 31, 2026. It was announced November 17, 2025 and initially framed as running to March 31, 2026 before being extended in later price guides. After the intro fills, the standard $349 monthly price applies.
This article summarizes FDA labeling, published research and company information current as of September 14, 2026. It is not medical advice and does not replace a conversation with your own healthcare provider. How we research and verify.